Wednesday, October 8, 2025

14:30 - 15:15

RAMÓN Y CAJAL ROOM

---

Overview

Sponsor: YVC Community

---

Details

In a rapidly evolving biotech and life sciences landscape, the due diligence (DD) process is both an art and a science — and it varies significantly across venture capital (VC), corporate venture capital (CVC), and pharmaceutical partnering strategies. This panel will bring together leading voices from each of these domains to unpack how different stakeholders approach sourcing, evaluating, and ultimately investing in new opportunities. From scouting strategies to milestone design, the session will explore the key components of due diligence across sectors. How do internal R&D teams shape the search for innovation? What’s the balance between financial modeling and long-term technological vision? And how do organizations support portfolio companies after the deal is closed? Attendees will gain a behind-the-scenes look at how investment decisions are made, risks evaluated, and value defined. Whether you're building a biotech startup, investing in innovation, or navigating strategic partnerships, this session will decode the nuances of due diligence and offer insights into the decision-making frameworks shaping the future of healthcare innovation.

---

Details